Investment Rating - The report does not explicitly provide an investment rating for the health sector in Cameroon, but it emphasizes the need for targeted policy interventions to improve health equity and access, particularly for vulnerable populations. Core Insights - Cameroon has made significant progress towards Universal Health Coverage (UHC), with the UHC Service Coverage Index doubling from 22 in 2000 to 44 in 2021, yet it still lags behind the averages for low- and middle-income countries (58) and the global average (68) [5][6] - The report highlights the importance of addressing health inequities, as disparities in access, service coverage, and financial protection persist across socioeconomic and geographic lines [6][7] - The findings from the Country Equity Diagnostic (CED) aim to guide policymakers and stakeholders towards reforms that ensure no individual is left behind in health improvements [7] Summary by Sections Background - Cameroon has made notable advancements in UHC, but significant opportunities for improvement remain, particularly in addressing disparities in health access and financial protection [5] Methods - The CED utilizes data from various household surveys to analyze health-related inequalities, focusing on health status, efficiency, access, and financial risk protection [11] Results - Key findings indicate that health improvements have been largely pro-poor, with significant progress in health status and service coverage driven by economically disadvantaged populations [12] - However, the poorest populations still lag in service coverage, particularly in immunization, and face high rates of foregone care due to financial and geographic barriers [12] - Geographic disparities are evident, especially in the North and Far North regions, which show worse health outcomes and service coverage [12] System Performance Goals - Health status and financial risk protection are critical performance goals, with the report emphasizing the need for policies that reduce out-of-pocket spending and improve access to quality care [14] Health Status - Infant and under-five mortality rates have declined, with improvements more pronounced among poorer populations, although inequalities in child mortality remain significant [15] - Childhood nutrition has seen modest improvements, but stunting and wasting rates remain high, particularly among low socioeconomic groups [19] Financial Risk Protection - Over half of the population reports out-of-pocket health spending, with the wealthiest quintiles spending more overall, while financial hardship is concentrated among poorer households [24][28] - The top 5% of spenders account for 50% of total health expenditure, highlighting the concentration of health spending among a small portion of the population [28] Intermediate Performance Objectives - Service coverage for reproductive, maternal, newborn, child, and adolescent health services has generally improved, but disparities persist, particularly in access to antenatal care and immunization [36] - Access barriers are significantly higher among the poorest households, with longer travel times to health facilities compared to wealthier households [39] Conclusions and Policy Implications - The CED provides evidence to target policies addressing health inequities, emphasizing the need for interventions that consider socioeconomic and geographic disparities [43] - Proposed policy design considerations include financing strategies, payment adjustments, and community outreach programs to improve service coverage among vulnerable populations [44][45]

Core Insights - Cambodia has officially launched a new National Sexual and Reproductive Health and Rights Strategy aimed at modernizing the healthcare system, adapting to climate change, and achieving Universal Health Coverage (UHC) [1] Group 1: Strategy Overview - The new strategy, titled "National Sexual and Reproductive Health and Rights Strategy (2025-2030)," is the fourth version developed by the Ministry of Health, based on reliable data from Cambodia and international organizations like WHO and UNFPA [1] - The strategy aims to improve sexual and reproductive health and rights, prevent the spread of infectious diseases, and enhance the health of mothers, infants, and children [1] Group 2: Implementation Goals - The strategy emphasizes translating plans into concrete actions with a clear implementation timeline and measurable outcomes [1] - The Ministry of Health will collaborate closely with relevant units and communities to understand and support the needs of women, partners, and youth, while ensuring privacy, trust, and dignity [1] Group 3: Health Indicators and Targets - Significant progress has been made in maternal and newborn health indicators since the end of the civil war, with maternal mortality rates dropping from 1,020 per 100,000 live births in 1990 to 189 in 2021, although there was a slight increase from 168 in 2016 [2] - The new strategy sets an ambitious target to reduce maternal mortality to below 70 per 100,000 live births by 2030 [2] - The proportion of births attended by skilled midwives has increased from 32% in 2000 to 89% in 2021, while the total fertility rate has decreased from 3.8 children per woman in 2000 to 2.7 currently [2] Group 4: Challenges and Issues - Teenage pregnancy and abortion among young girls have become significant public health issues, with the adolescent birth rate for females aged 15-19 rising from 8% to 12% between 2010 and 2014, particularly among uneducated young women [3] - Urbanization and population mobility have introduced new challenges, with an increase in abortion rates in Phnom Penh attributed to the influx of young female migrant workers, creating a vulnerable group with limited access to modern contraceptives [3]

Core Insights - The Philippine pharmaceutical market is projected to generate $2 billion in revenue this year, driven by the demand for generic drugs and the implementation of Universal Health Coverage (UHC) [2] - The market is expected to grow at a stable rate of 4.1% annually until 2029 [2] Industry Overview - The Philippine pharmaceutical industry remains reliant on imports, with a steady increase in drug imports from 2019 to 2024, while exports have been declining [2] - In the first half of 2025, exports decreased by 25%, whereas imports grew by 5% [2] Strategic Initiatives - The Philippine Board of Investments (BoI) has implemented a comprehensive roadmap for the pharmaceutical industry (IRPPI) since 2023, which includes the release of guidelines for pharmaceutical economic zones and the simplification of export processes [2] - Plans are underway to establish a Philippine Virology Research Institute, aimed at enhancing the flexibility and resilience of the industry’s value chain [2] - The goal is to increase domestic manufacturers' capacity to produce registered drugs to 60%, positioning the Philippines as a major producer of essential medicines and services [2]